Yuki Yajima

Structural characterization of the epitopes of the monoclonal antibodies 473HD, CS-56, and MO-225 specific for chondroitin sulfate D-type using the oligosaccharide library

Yumi Ito, Megumi Hikino, Yuki Yajima et al. · Glycobiology · 2004 · 112 citations · Full text

Sclerostin, Glycobiology, Immunology +20

Heterogeneity of the Chondroitin Sulfate Portion of Phosphacan/6B4 Proteoglycan Regulates Its Binding Affinity for Pleiotrophin/Heparin Binding Growth-associated Molecule

Nobuaki Maeda, Jue He, Yuki Yajima et al. · Journal of Biological Chemistry · 2003 · 96 citations · Full text

Glycobiology, Binding Affinity, Cytoskeleton +22

CD47 blockade enhances the efficacy of intratumoral STING-targeting therapy by activating phagocytes

Akemi Kosaka, Kei Ishibashi, Toshihiro Nagato et al. · The Journal of Experimental Medicine · 2021 · 51 citations · Full text

Immunology, Immune Regulation, Immunoediting +20

A critical role of STING-triggered tumor-migrating neutrophils for anti-tumor effect of intratumoral cGAMP treatment

Marino Nagata, Akemi Kosaka, Yuki Yajima et al. · Cancer Immunology Immunotherapy · 2021 · 26 citations · Full text

Anti-tumor Effect, Cancer Immunosurveillance, Granulocyte +9

Intratumoral STING activations overcome negative impact of cisplatin on antitumor immunity by inflaming tumor microenvironment in squamous cell carcinoma

Shohei Harabuchi, Akemi Kosaka, Yuki Yajima et al. · Biochemical and Biophysical Research Communications · 2019 · 24 citations · Full text

Intratumoral Sting Activations, Negative Impact, Squamous Cell Carcinoma +9